Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury with Metabolic Syndrome: a Combination Approach with Lactate Administration and Ischemic Preconditioning

NCT06825143 is registered in ClinicalTrials.gov with Gary Van Guilder as lead sponsor.

NCT NCT06825143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06825143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury with Metabolic Syndrome: a Combination Approach with Lactate Administration and Ischemic Preconditioning
Lead sponsor
Gary Van Guilder
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
June 30, 2030
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, endothelial function (reactive hyperemia), ischemic preconditioning, metabolic syndrome, vascular injury